“atrial-fibrillation” Archives

Entry Author Date Location
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
So Far, Little Proof That Digital Health Is Healthy. Does It Matter? 10/07/14 National
San Diego Life Sciences Roundup: Isis, Elcelyx, Acutus, and More 06/27/13 San Diego
Ailing ARCA Biopharma Seeks $20M to Fund Trials, Stay in Business 05/30/13 Boulder/Denver
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender 11/07/11 New York
UW Spinoff Cardiac Insight Looks to Spot Common Cause of Stroke with Stick-On Device 11/02/11 Seattle
Latest in Stroke-Prevention Saga: FDA Panel Backs Drug From J&J and Bayer 09/09/11 New York
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer 09/08/11 New York
Bristol and Pfizer Get Boost from Apixaban Data 06/23/11 New York
$6.6M for Cardiorobotics 03/01/11 Boston
CardioFocus Finds $30.6M for Atrial Fibrillation Treatment 02/25/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Boston Scientific Acquires Atritech 01/19/11 Boston
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat 10/28/09 San Diego
Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery 08/06/09 Boston
Medtronic To Pick Up Ablation Frontiers for $225 Million Upfront 01/12/09 San Diego
Page 1 of 1